Supernova Invest supports high-potential deep tech start-ups which use highly differentiating and disruptive technologies to create products and services that meet massive identified needs.
Supernova Invest maintains close relationships with its companies and is in frequent contact with the leaders of innovative start-ups, supporting them from launch to maturity, not only in their fundraising but also, and more importantly, in their technical, industrial, and commercial development.
Well-accustomed to the long investment cycles typical of deep tech, Supernova Invest benefits from a unique track record in this space, as reflected in its 30 or so successful trade exits and six IPOs.
Chief Executive Officer - Algaia
“We believe in you and your management team, so we decided to allocate even more funds than you requested.” I will never forget those words spoken by Celia Hart and Régis Saleur from SuperNovaInvest back in 2014 when Algaia did not even exist; it was just a start-up with another name, with the goal of completely reinventing the algae space.
Today, Algaia has revenue of about €20 million, 100 people, and at least double-digit growth. It was named “Entrepreneur of the Year – Born Global” by E&Y in 2018, and has three locations in France where it develops, produces, and sells algae extracts for food, cosmetics, plant health, and medical device applications in more than 45 countries worldwide.”
CEO - En Voiture Simone
CEO - Naskeo
CEO & Co-Founder - Blue Valet
CEO, PHD – UROMEMS
FOUNDER AND CEO OF KERANOVA – FOUNDER OF EYETECHCARE
FOUNDER AND CEO – SYMBIOFCELL
CEO - Soitec
CO-FOUNDER AND CEO – APIX ANALYTICS
A budget of 1.8 billion euros has been allocated to the quantum plan launched by Emmanuel Macron on Thursday 21st of January 2021. The development of quantum technology and its associated capabilities has major strategic and economic stakes as it constitutes the next...
WeAreDeeptech is a series of cross-over meetings between the leading entrepreneurs of the French deeptech and the Supernova Invest team. On the agenda: major innovations, technological leadership, promising sectors … and economic influence. Because tomorrow...
Catherine Dunand brings her expertise in healthcare technological innovation to support Diabeloop's growth and international development. Diabeloop announced today the appointment of Catherine Dunand as Chairman of the Board of Directors, succeeding Dr Guillaume...